Fingerprint
Dive into the research topics of 'Dolutegravir plus lamivudine dual therapy - A new option for initial antiretroviral therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dolutegravir plus lamivudine dual therapy - A new option for initial antiretroviral therapy
M. Fida, S. A. Rizza, Z. Temesgen
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations